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Smoking, Mental Health, and Alcohol and Other Drug Treatment: A Review 
Abstract 
Smoking tobacco is the largest single risk factor for premature death in developed 
countries. It is also associated with the greatest economic cost of all drugs in 
Australian society. In addition to the health and economic consequences associated 
with smoking, it has also been associated with mental health problems. Smoking has 
been associated with anxiety, depression and stress, as well as more pervasive 
disorders such as panic disorder and agoraphobia. It is not clear whether smoking 
contributes to mental health problems or individuals with mental health problems 
smoke to alleviate symptoms. It may be there are genetic factors that contribute to 
both. The various forms of smoking cessation interventions include nicotine 
replacement therapies (NR T), brief interventions, telephone counselling, self-help 
materials, banning smoking in certain areas, and individual counselling or group 
therapy. Research suggests that combinations ofNRT for extended periods of time is 
the most effective smoking cessation intervention. Rates of smoking remain high 
amongst people with alcohol and other drug use disorders. Mortality rates from 
smoking are much higher for these individuals compared to the general community. 
Despite smoking cessation not being encouraged for those in treatment for alcohol 
and other drug use, research suggests that treating smoking for these individuals does 
not put at risk other drug treatment and may actually improve treatment outcomes. 
The "stages of change" model theorises that smokers are in one of five stages of 
readiness to change their smoking behaviour at any one time. There are also ten 
different processes that people use to progress through the stages. A large body of 
research supports the "stages of change" model. There appears to be little research on 
smoking and stages of change amongst alcohol and other drug treatment populations. 
The high mortality rate resulting from smoking for this population warrants further 
research. 
Author: Thomas Hopkins 
Supervisors: Dr Deborah Gardner 
Dr Shelley Beatty 
Submitted: October, 2008 
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Introduction 
The relationship between smoking tobacco and chronic health problems is 
well established (Bergen & Caporaso, 1999). Various health problems such as cancer 
of the lungs, oesophagus, cervix, anus, throat and bladder, as well as an increased risk 
of heart disease and stroke are only some of the problems associated with smoking 
(Ryder Salmon & Walker, 2001). In addition, smoking is the largest single risk factor 
for premature death in developed countries (WHO, 2007). The costs of tobacco use 
goes beyond just health problems in society. A recent report found tobacco use to be 
associated with the greatest economic cost in society when compared to alcohol and 
illicit drugs (Collins & Lapsley, 2007). 
Less appears to be known about the relationships between smoking and 
mental health problems. Nonetheless, the rates of smoking have been found to be 
higher amongst psychiatric patients than in the general community (Hughes, 
Hatsukami, Mitchell & Dahlgren, 1986). Smoking has also been found to have strong 
associations with depression (Kinnunen, Haukkala, Quiles, Spiro & Garvey, 2006; 
Williams & Ziedonis, 2004), anxiety (West & Hajek, 1997) and stress (Parrot, 1993). 
In addition to anxiety, depression and stress, smoking has also been found to 
be associated with other drug dependencies (Williams & Ziedonis, 2004). In a study 
by Breslau et al. (1996), it was found that smoking and alcohol dependency were 
significantly associated in the population samples. The rates of smoking among 
individuals with substance use disorders have been found to be double to triple that of 
the general community (Batel, Pessione, Maitre & Rueff, 1995). In addition, many of 
the individuals that are successfully treated for their drug dependencies will 
experience a reduced quality of life and longevity due to smoking (Hurt et al., 1996). 
Indeed it is tobacco (not alcohol or illicit drugs) that has been found to be the leading 
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cause of death among former patients of a community addictions treatment program 
(Hurt et al.). In contrast to the commonly held belief among addiction treatment 
programs that attempting to quit smoking whilst being treated for drug addiction may 
jeopardise effective treatment, there are some findings that suggest that including 
smoking cessation interventions in addiction treatment programs may actually 
improve treatment outcomes (Bobo, Mcilvain, Lando, Walker & Leed-Kelly, 1998). 
The psychoactive ingredient in tobacco is nicotine, which is a CNS stimulant 
(Ryder et al., 2001). It has been found that nicotine increases the levels of the 
neurotransmitter dopamine in the part ofthe brain that regulates feelings of pleasure 
(Epping-Jordan, Watkins, Koob & Markou, 1998). Nicotine has been found to 
contribute to dependence which results in physical and neurobiologic withdrawal 
symptoms on cessation (Epping-Jordan et al., 1998). 
A number of different smoking intervention strategies have been found to be 
effective in aiding smoking cessation. The various forms of nicotine replacement 
therapies that have been found to be effective are the transdermal patch, nasal spray, 
inhaler, chewing gum, tablet or lozenge (Silagy, Mant, Fowler & Lodge, 1994). This 
enables the smoker to reduce the withdrawal symptoms whilst giving up smoking. 
Other strategies used in the cessation of smoking include brief interventions, 
telephone counselling, self-help materials, banning smoking in certain areas, and 
individual counselling or group therapy (Fitchenburg & Glantz, 2002; Foulds et al, 
2006; Hajek, Taylor & Mills, 2002; Murray et al., 2008; Pan, 2006). 
Prochaska and Velicer (1997) posited that a smoker is in one of five stages of 
change at any given time. The five stages of change are precontemplation, 
contemplation, preparation, action, and maintenance. The stage of change an 
individual is in has been found to influence their relative success at smoking cessation 
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(DiClemente et al., 1991). In addition to the five stages of change, Prochaska and 
Velicer also identified 10 processes of change which an individual uses at different 
stages. These processes are consciousness raising, self-liberation, social-liberation, 
self-reevaluation, environmental reevaluation, stimulus control, counterconditioning, 
dramatic relief, contingency management, and helping relationships. 
The purpose of this paper is to review the literature on smoking and mental 
health, the various smoking cessation interventions, the research regarding smoking 
and smoking cessation amongst drug treatment populations, and the findings 
regarding smoking cessation and the stages of change model. The paper will begin 
with some recent findings on the societal costs of tobacco use in Australia, as well as 
some recent statistics on the mortality and morbidity attributable to tobacco use in 
Australia. This will be followed by a review of the various findings on the association 
between tobacco and mental health as well as the findings regarding smoking 
cessation strategies. Following this will be a review on the various findings regarding 
smoking cessation in drug addiction treatment settings, as well as a look at the 
findings regarding the influence of an individual's stage of change on their smoking 
cessation success. 
Literature Review 
The costs of tobacco use in Australia are not just limited to the large number 
of deaths caused every year. Collins and Lapsley (2007) have outlined the total social 
costs, in an economic sense, of drug abuse in Australia. They define economic costs 
of drug abuse as "the value of the net resources that in a given year are unavailable to 
the community for consumption or investment purposes as a result of the effects of 
past and present drug abuse, plus the intangible costs imposed by this abuse" (Collins 
& Lapsley, 2007, p. 2). Of the total social cost of drug abuse in Australia in 2004/05, 
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tobacco accounted for $31.5 billion, which was 56.2 percent (Collins & Lapsley). 
Alcohol was the next highest at $15.3 billion and all illicit drugs together accounted 
for $8.2 billion. Probably the most frightening finding by Collins and Lapsley was 
that regarding involuntary smoking by Australian youth. The term involuntary 
smoking referred to passive smoking as well as the effects of smoking on an unborn 
child. It was found that for children under 15 years of age in 2004/05, involuntary 
smoking accounted for 25 percent of deaths, 96 percent of hospital bed-days and 91 
percent of hospital costs. These deaths and hospital admissions resulted from 
conditions such as lower respiratory tract infections, Crohn's disease, ulcerative 
colitis, antepartum haemorrhage, low birthweight, SIDS, asthma, otitis media, as well 
as fire injuries. Tobacco use accounted for 14, 901 involuntary and voluntary deaths 
of people aged fifteen years and over. 
There appears to be relationships between the amount an individual smokes 
and anxiety and depression. In a study that looked at these relationships in teenagers, 
it was found that participants who reported high levels of depression and anxiety were 
twice as likely to be smokers after controlling for potential confounds (Patton et al., 
1996). Moreover, regular smokers were almost twice as likely as occasional smokers 
to report high levels of anxiety and depressive symptoms. This finding indicates that 
there may be relationships between level of nicotine dependence and anxiety and 
depression. Goodman and Capitman (2000) also found that current tobacco use 
among teenagers was a powerful determinant of developing a high level of depressive 
symptoms. 
Some findings suggest that even occasional smoking among adolescents can 
contribute to mental health symptoms. In a study on anxiety and depressive symptoms 
among adolescent smokers, Dudas, Hans and Barabas (2005) found there to be a 
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significant difference between occasional smokers and regular smokers. Occasional 
smokers were defined as those who smoke on some days but not everyday and regular 
smokers were defined as those who smoke at least once a day. Those who were 
regarded as occasional smokers were found to exhibit higher levels of anxiety on state 
as well as trait measures, compared to their non smoking peers. Regular smokers were 
found to show higher levels of depression than either occasional smokers or their non 
smoking peers. Similar findings were found by Breslau, Kilbey and Andreski (1992) 
who found that depression was more strongly associated with heavy smoking and 
nicotine dependence than lower levels of use. These findings suggest that even 
occasional smoking can have an effect on mental health and that heavier smoking may 
be more associated with depressive symptoms. 
In addition to depression and anxiety, smoking has also been found to be 
associated with more pervasive mental health disorders. Heavy smoking of tobacco 
during adolescence has been associated with an increased risk of developing 
agoraphobia, generalised anxiety disorder, and panic disorder during early adulthood 
after controlling for age, gender, difficult childhood temperament; alcohol and other 
drug use; anxiety and depressive disorders during adolescence; and parental smoking, 
educational level, and psychopathology (Johnson et al., 2000). 
In a study by Parrot (1993) it was found that although smokers experienced a 
self-reported decrease in stress after smoking cigarettes, they experienced higher 
general levels of stress than non-smokers. It was also found that after smoking 
cessation, smokers' general levels of stress were reduced. These findings suggest that 
smoking may contribute to increased stress levels in smokers. 
It has been suggested that there is a causal link between depression and 
smoking. This link appears to go in both directions. For example, depression may 
Smoking, Mental Health, and AOD Treatment 8 
result from the neurochemical changes caused by smoking, and in contrast, 
individuals with depression may self-medicate the negative feelings by smoking 
(Carmody, 1989; Gilbert, 1979). A twin study conducted by Kendler et al. (1993) 
found there to be higher rates of smoking and major depression in the co-twins of 
identical twins than in the co-twins of fraternal twins, suggesting that there may be 
genetic factors that predispose individuals to smoking and major depression. Evidence 
also suggests that it is only current smoking that is associated with depressive 
symptoms. A study of depression and smoking in men over 25 years conducted by 
Kinnunen et al. (2006) found that current smokers scored significantly higher on 
depression scales than quitters, those who have never smoked and former smokers. 
Interestingly, it was also found by Kinnunen et al. that none of the depression 
measures predicted smoking cessation. Smokers with higher depression scores were 
just as likely to give up smoking as those with lower scores. 
Mental health disorders also appear to be associated with the maintenance of 
smoking because of the effect from the withdrawal of smoking. In a study on nicotine 
withdrawal symptoms among individuals with psychiatric disorders it was found that 
individuals with histories of major depression or any anxiety disorder reported more 
severe nicotine withdrawal symptoms than those with no history of either disorders 
(Breslau et al., 1992). This finding is consistent with a study by Covey, Glassman and 
Stetner (1990), in which it was found that smokers with histories of major depression 
experienced more psychological distress, anger, and other disturbances that 
characterise withdrawal than those without such histories. Interestingly, Breslau et al. 
(1992) found that a history of any anxiety disorder, but no history of alcohol or other 
drug disorder, was associated with more severe nicotine withdrawal. This finding 
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suggests that smoking cessation attempts may not put at risk recovery from alcohol 
and other drug use. 
The more severe withdrawal symptoms experienced by individuals with 
anxiety and depressive disorders may influence their success at cessation attempts. A 
study by Glassman et al. (1988) found that smokers who had a history of major 
depressive disorder failed at twice the rate of those without, eventhough they were 
not depressed at the time. Similar findings were found by Pomerlau, Adkins and 
Pertschuk (1978) when they demonstrated that smokers who identified negative affect 
as a reason for smoking were more likely to fail in their cessation attempts. Negative 
affect was a broad concept used in the earlier studies on smoking referring to states 
such as depressed mood, anxiety, tension and/or anger (Glassman, 1993). 
Due to the many negative consequences associated with smoking, many 
smoking cessation intervention strategies have been developed throughout the years. 
Nicotine replacement therapies (NRT) work by replacing the nicotine delivered by 
cigarettes so as to reduce the negative affect associated with nicotine withdrawal 
(Gold, Ruby & Harvey, 2002). In a meta-analysis on the efficacy ofNRT for smoking 
cessation conducted by Silagy, Mant, Fowler and Lodge (1994), it was found that 
NRT were effective in aiding smoking cessation. However, all forms ofNRT were 
associated with a high relapse rate suggesting that minimising relapse is important if 
long-term smoking cessation is to be maintained. Other studies have shown NRT as 
well as bupropion hydrochloride (referred to as bupropion) as being effective smoking 
cessation strategies (Gold et al.; Jorenby, 2001). Bupropion is an anti-depressant that 
works on the central nervous system to reduce the withdrawal symptoms during 
smoking cessation (Gold et al.). 
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There is also evidence to suggest that using combinations of medications for 
smoking cessation can be effective. Some studies have shown combinations ofNRT 
to be more effective when compared with an NRT on its own (Croghan et al., 2003; 
Fagerstrom, Schneider & Lunell, 1993 ). A study by Steinberg, Foulds, Richardson, 
Burke and Shah (2006) which assessed the efficacy of combinations of medications 
for smoking cessation found that the use of combinations of medications was 
associated with a higher likelihood of remaining abstinent. Although this trend 
reduced somewhat over time, a six month follow-up indicated that it was continuing. 
Interestingly, those who received combinations of medications were assessed as being 
more nicotine dependent at the beginning of the study, but they still did as well as less 
dependent smokers at both follow-ups. Steinberg et al. also found that longer duration 
of medication use was associated with better outcomes. It was found that those that 
continued to use medications had considerably better abstinence rates at six months. 
In recent years, doctors have been encouraged to routinely offer smoking 
cessation advice to all presenting patients who are smokers (Mullins, Livingston & 
Borland, 1999; Murray et al., 2008). The findings on the effectiveness of this 
approach are mixed. Murray et al. found that proactively identifying smokers who 
wanted to quit in primary care populations and referring them to a cessation service 
increased contacts with cessation services and the number of quit attempts. However, 
it was found that at the population level there was no significant impact on actual quit 
rates or reported cigarette consumption. Hajek, Taylor and Mills (2002) found that a 
single session brief intervention to prevent cardiac inpatients from returning to 
smoking after discharge was ineffective. The researchers concluded that single session 
brief interventions are insufficient to influence highly dependant smokers to quit. A 
study conducted by Butler, Pill and Stott (1998) on patients' perceptions of doctors' 
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advice to quit smoking found that many patients were sceptical about the influence of 
doctors' words on their smoking habits, making the point that the negative effects of 
smoking are already well known. In addition, patients who were not ready to quit 
reported shrugging it off, feeling guilty, getting annoyed, or changing their help 
seeking behaviour, when being advised to quit. Two patients even reported putting 
their health at risk by not attending for needed medical help because they feared being 
talked to about their smoking. It was also found, however, that the patient's 
receptiveness to advice depended largely upon how the advice was delivered. 
Interventions that patients found acceptable were those conveyed in a respectful tone 
that was not preaching, showed support and caring, and attempted to understand them 
as a unique individual. Stott and Pill (1990) had similar findings from their study on 
the effect of doctor's advice. This suggests that the manner in which advice is given 
by doctors is equally as important as the advice itself. 
In a systematic review of the effect of smoke-free workplaces on smoking 
behaviour, it was found that totally smoke-free workplaces were associated with 
reductions in prevalence of smoking of 3.8% (Fitchenburg & Glantz, 2002). In 
addition, smoke-free work places were also associated with smokers smoking 3.1 
fewer cigarettes per day. It was estimated by the authors that if all workplaces became 
smoke free in the United States and the United Kingdom, consumption per capita in 
the entire population would drop by 4.5% in the United States and 7.6% in the United 
Kingdom. This study demonstrated the strong effect that smoking restrictions can 
have in reducing rates of smoking. 
In a meta-analysis on proactive telephone counselling as an adjunct to minimal 
intervention for smoking cessation conducted by Pan (2006), it was found that 
proactive telephone counselling is effective as an adjunct to other minimal 
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interventions for younger, male, light-smoking individuals. Minimal interventions 
were defined as a single or combination of less intensive or self-help interventions 
such as nicotine replacement therapy, reactive telephone hotlines or helplines, 
computer programs or the internet, and physician's advice. The results of the meta-
analysis indicated that researchers and health care providers may need to focus on the 
individual as much as on the intervention process to provide effective interventions. 
This means that smoking interventions should take into account the characteristics of 
the individuals that they will be delivered to and be developed accordingly. 
There is evidence to suggest that an individual's success at smoking cessation 
can depend on their level of nicotine dependence. Foulds et al. (2006) found that the 
measure of how long an individual takes to smoke after waking in the morning was 
predictive of their smoking cessation outcome. After having controlled for other 
predictors, those participants who usually smoked more than 30 minutes after waking 
in the morning were twice as likely to succeed at quitting than those who smoked 
within five minutes of waking. How long an individual takes to have their first 
cigarette for the day is generally a marker of nicotine dependence, so this finding 
suggests that an individual's level of nicotine dependence has a bearing on their 
cessation attempts. Other studies have reported similar findings on cessation success 
and time of first cigarette for the day (Harris et al., 2004; Hymowitz et al., 1997; 
Judge et al., 2005). For example, Foulds et al. found that those participants who 
sometimes woke in the night to have a cigarette or use tobacco were significantly less 
likely to remain abstinent at six month follow-up, after controlling for other 
predictors. This is also a marker of nicotine dependence and further supports the 
concept that smoking cessation success depends on an individual's level of nicotine 
·dependence. 
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Socioeconomic status has also been found to be a predictor of success at 
smoking cessation. Foulds et al. (2006) found that participants with only a high school 
education were significantly less likely to have remained abstinent at both follow-up 
periods compared with participants who had a university degree. In addition, being 
unemployed predicted a poor outcome at four weeks follow-up, and not having 
private health insurance predicted a poor outcome at 26 week follow-up. The 
researchers suggested that the effect of socioeconomic background on outcomes is a 
result ofthe social environment of those with a lower socioeconomic background. For 
example, those with a lower socioeconomic background are less likely to work in 
smoke-free environments and are more likely to have friends and family who smoke. 
Due to many factors, smoking has declined in developed countries in recent 
years (WHO, 2007). Despite this, there has been no significant reduction in smoking 
among individuals with substance use disorders (Kalma11, 1998). Indeed, many drug 
treatment counsellors discourage clients from quitting smoking in early stages of 
treatment (Brigham, Schroeder & Schindler, 2007). One reason that smoking 
cessation is not advocated by drug treatment programs is that there is a concern that 
this could deter some individuals who are willing to address their other substance use 
problem but not their smoking (Bobo, Mcilvain, Lando, Walker & Leed-Kelly, 1998). 
Another reason is the belief that encouraging smoking cessation during drug treatment 
could jeopardise effective treatment (Campbell, Wander, Stark & Holbert, 1995). 
Contrary to this commonly held belief, the research suggests that smoking cessation 
does not risk successful substance use treatment. A study by Martin et al., (1997) in 
which 205 recovering alcoholics were assigned to one of three smoking cessation 
groups found that at 12-month follow-up, only 4% of all participants had relapsed to 
use alcohol or other drugs. However, the lack of a non smoking cessation control 
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group limited the study. Further support for these findings came from a study 
conducted by Burling, Marshall and Seidner (1991) in which 39 inpatient alcohol 
dependent men were randomly assigned to a tobacco intervention or waitlist control 
group. No adverse effect was found for the tobacco intervention group as compared to 
the waitlist control group. In addition, Bobo et al. (1998) from their study of a 
randomised controlled trial community intervention involving 575 individuals from 
12 residential treatment programs had a primary finding that urging alcohol dependant 
individuals to quit smoking does not compromise treatment, even in early stages of 
recovery. No adverse effect was detected on participants being able to remain 
abstinent after treatment discharge. It was actually found that the likelihood of 
remaining abstinent for those who were repeatedly encouraged to quit smoking was 
almost twice that of the control group over the one year follow-up. The researchers 
attributed the more favourable outcomes for those exposed to the tobacco intervention 
to a number of factors. It was likely that some of the aspects from the tobacco 
counselling reinforced key elements of effective alcohol treatment. In addition, the 
counselling sessions encouraged personal responsibility and supported a drug-free 
lifestyle, messages which may have generalised back to alcohol. The study was 
limited by the fact that all study data, apart from the analysis of saliva samples, were 
gathered via self-report. However, the researchers suggested that was unlikely to bias 
their primary finding as they were unable to detect evidence of differential reporting 
between intervention and control groups. This is an interesting finding and is contrary 
to what is believed throughout the addictions field. 
A number of studies have demonstrated the harm oftobacco use among 
alcohol and other drug dependant individuals. In an 11-22 year follow-up study of 845 
individuals treated for drug dependency conducted by Hurt et al. (1996), it was found 
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that those treated for drug dependency had a mortality rate almost three times that of 
the general community of the same age. Interestingly, the majority of deaths were not 
a result of the drugs that they were treated for but were attributed to conditions 
resulting from tobacco use such as lung cancer and heart disease. Another study 
conducted by Hser, McCarthy and Anglin (1994) found that opiate addicts who 
smoked had a mortality rate four times that of opiate addicts who did not smoke at 21-
24 year follow-up. In addition, it was found that the relapse rate amongst the survivors 
who did not smoke was less than that of the survivors who continued to smoke. 
However, because Hser et al.'s data was based on observational, retrospective data, 
they did not know whether smoking cessation occurred around the time of treatment 
or years later. 
Not all research suggests that smoking cessation does not jeopardise effective 
drug treatment. There is also evidence suggesting that smoking cessation can have a 
detrimental effect on alcohol and other drug treatment. Conner, Stein, Longshore and 
Stacey (1999) found that the introduction of a mandatory smoking abstinence policy 
for polydrug users in treatment resulted in an increase in cocaine use. It was suggested 
by the researchers that tobacco had likely served as a replacement for cocaine 
previous to the ban. Other studies have also found that individuals in drug treatment 
increase their tobacco use as a replacement drug (Campbell et al.,1995). However, the 
majority of research reviewed suggests that smoking cessation does not jeopardise 
alcohol and other drug treatment and may actually improve treatment outcomes. 
The "stages of change" model was developed from observations of how 
people quit smoking on their own and has proven to be effective in the development 
of smoking cessation interventions (Prochaska, DiClemente, Velicer & Rossi, 1993 ). 
Originally developed for quitting smoking, the model can be used for any behaviour 
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change, in particular in the field of alcohol and other drugs (Ryder, 1999). The five 
stages can have a bearing on how successful an individual will be quitting smoking or 
changing any other kind of behaviour (Prochaska & Velicer, 1997). People in 
precontemplation are not intending to quit smoking in the near future, usually 
measured as the next six months. Individuals in the precontemplation stage may be 
underinformed of the full extent of the consequences of their behaviour or may be 
demoralised after failed attempts at behaviour change in the past. The latter is more 
likely the case for smokers who are in precontemplation. Precontemplators are 
resistant and are not ready for any interventions. People in the contemplation stage are 
intending to quit in the next 6 months. They are more aware of the benefits of 
changing their behaviour than people in precontemplation but are also very aware of 
the costs. People in contemplation to be in a state of ambivalence and people can be in 
the contemplation stage for a very long time. They are typically not ready for action-
oriented interventions. People in the preparation stage are intending to quit in the 
immediate future; usually measured as in the next 30 days. Generally these people 
have taken some form of action over the past year, and usually have a plan of action 
such as having sought counselling, consulted their physician, or bought a self-help 
book. People in the action stage have stopped smoking within the last 6 months. 
When the model is applied to smoking, only complete abstinence qualifies as being 
action. Simply cutting down on the number of cigarettes or switching to lower tar or 
nicotine brands does not qualify as being action. This is because there is no safe level 
of use for tobacco (WHO, 2007). People in the maintenance stage are in the process of 
preventing relapse but do not have to focus on maintaining their change as much as 
those in action. The temptation to relapse becomes less and less for those in 
maintenance and they become increasingly confident that they can continue with their 
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changed behaviour. It is estimated that people can be in the maintenance stage from 
anywhere between six months and five years. Although not formally a stage in the 
model, relapse is an expected part of the progression through the stages. However, 
individuals would rarely relapse all the way back to precontemplation. Usually relapse 
would take people back to contemplation or preparation. 
In addition to the five stages of change, Prochaska and Velicer (1997) 
identified ten covert and overt processes that people use as they progress through the 
stages. The covert, internal processes are associated more with the early stages of 
change and the more overt, behavioural processes are associated more with the later 
stages of change. Consciousness raising is the process by which an individual 
becomes more aware of the consequences associated with their behaviour. An 
individual would likely go through this process in precontemplation. Dramatic relief 
is the process where by an individual has an emotional experience related to their 
behaviour. For example, an individual may have a family member who dies as a result 
of a smoking-related illness which may trigger that person to move from 
precontemplation to contemplation. Self-reevaluation involves an individual assessing 
themself, both cognitively and affectively, with and without the behaviour they want 
to change. This process usually occurs in the contemplation stage. Environmental-
reevaluation involves an individual making a cognitive and affective assessment of 
the impact that their behaviour is having on their social environment, such as the 
effect of smoking on others. This process usually occurs in the precontemplation or 
contemplation stages. Self-liberation is the process whereby an individual begins to 
believe in their ability to change and the commitment to act on that belief. Commonly 
referred to as willpower, this process generally occurs in the preparation stage. Social 
liberation is the process whereby an individual's social environment provides more of 
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an opportunity for the behaviour change. Smoke-free workplaces are an example of 
social-liberation. Counterconditioning involves the replacing of the unwanted 
behaviour with new healthy behaviours. For example, doing exercise as a replacement 
for a morning cigarette. This process would generally occur in the action stage. 
Stimulus control is the process whereby an individual removes stimuli from the 
environment that may prompt a relapse to the changed behaviour. For example, 
someone who has just given up smoking would benefit from throwing out all ashtrays 
and lighters. This is typically an action process. Contingency management is the 
process whereby an individual treats themself for reaching certain goals in their 
behaviour change. For example, someone who is stopping smoking could use the 
money saved from cigarettes to buy something they want as a reward. This is also 
typically an action process. The final process, helping relationships, involves 
establishing a network of supportive people that can help maintain the desired change. 
A counsellor can be an example of a helping relationship. This is also an action 
process. 
Many research findings support the "stages of change" model for smoking 
cessation. A study conducted by DiClemente et al. (1991) analysed the accuracy of 
the stages precontemplation, contemplation, and preparation amongst smokers. The 
results strongly supported the stages of change model. Smokers were assessed for 
their stage of change and then were followed-up at one and six months. At both 
follow-ups, significantly more people who were previously assessed as being in the 
preparation stage had made quit attempts than in other stages and significantly more 
contemplators had made quit attempts than precontemplators. A study conducted by 
Prochaska, V elicer, Fava, Rossi and Tsoh (200 1) evaluated a stage-based expert 
system intervention for smoking cessation. The stage-based expert system 
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individualised the interventions to the participants' stage of change and, using 
computers, interacted with them around the processes and principles that are 
necessary for them to progress. Prochaska et al. found that they were able to achieve a 
25% abstinence rate at 24 month follow-up. This was a good result considering that 
out of their population, more than 40% were not intending to quit. These findings 
demonstrated the efficacy of the stages of change model in that interventions tailored 
to individual's stage of change produced abstinence in people that other interventions 
would normally fail with. The highest abstinence rates were found in people in 
preparation, contemplation, and precontemplation, respectively. These findings 
suggest that the success of an intervention depends upon the amount of preparation 
smokers have undertaken prior to taking action. 
The "stages of change" model has been shown to be effective across different 
fields. A study by Brogan, Prochaska and Prochaska (1999) found that when the 
model was applied to the change process in psychotherapy it was shown to be a good 
predictor of who would remain in treatment. A study conducted by Acton, Prochaska, 
Kaplan, Small and Hall (2001), which examined the association between depression 
and stages of change for smoking cessation in a psychiatric outpatient sample 
supported several tenets ofthe model. The use of behavioural processes increased 
from precontemplation to maintenance. In addition, the use of experiential processes 
was high across all stages. However, the therapy often focused on processes such as 
consciousness raising and self-reevaluation so it is possible that these processes may 
have spilt over to the context of smoking cessation, thus accounting for these 
processes occurring in the later stages of change. An interesting finding was the 
relationship between stage of change and depression. It was found that contemplators 
had elevated depression scores. The researchers attributed this to possibly being the 
Smoking, Mental Health, and AOD Treatment 20 
dread felt by smokers who are intending to quit in the next six months. In addition to 
the dread, the researchers suggested that these contemplators may feel dejection over 
the discrepancy between their goal of abstinence and their current smoking behaviour, 
and such dejection can lead to depression. This could be a possible reason for the 
increased depressive symptoms found amongst smokers compared to non smokers. 
Pearlman, Wernicke, Thorndike and Haaga (2004) have also supported the 
"stages of change" model. They found that individuals in later stages of change have 
more positive outcome expectancies regarding quitting smoking and more negative 
outcome expectancies regarding continuing smoking. This finding is supported by 
previous studies (DiClemente et al., 1991; Prochaska et al., 1994). Pearlman et al. 
suggested that smoking cessation programs should utilise this finding and develop 
programs that increase awareness about the benefits and costs of smoking. 
Further support for the "stages of change" model was found by DiClemente et 
al. (1991). They found that there were differences in the number oflifetime quit 
attempts made by people at different stages of change with precontemplators reporting 
the lowest number oflifetime quit attempts. In addition, DiClemente et al. also found 
significant differences across stages of change in regards to individual's self-efficacy 
beliefs for quitting smoking. Precontemplators were found to report the most 
temptation to smoke and the lowest level of confidence in their ability to stop 
smoking. Confidence about one's ability to quit smoking significantly increased from 
precontemplation to contemplation. 
Conclusion 
The purpose of this paper was to review the literature on smoking and mental 
health, the various smoking cessation interventions, the research regarding smoking 
and smoking cessation amongst drug treatment populations, and the findings 
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regarding smoking cessation and the stages of change model. In addition to the many 
deaths caused from smoking, it also causes the most economic costs in Australian 
society of all psychoactive drugs (Collins & Lapsley, 2007). Tobacco is also 
responsible for a large amount of the mortality and illness of Australian youth, due to 
involuntary smoking (Collins & Lapsely). 
There is a large amount of evidence linking smoking and mental health 
symptoms, particularly anxiety and depressive symptoms (Breslau et al., 1992; Patton 
et al., 1996). However, smoking has also been found to be associated with more 
pervasive mental health disorders, such as panic disorder and agoraphobia (Johnson et 
al., 2000). It has been suggested that there is a causal link between smoking and 
mental health problems (Carmody, 1989; Gilbert, 1979). The direction of this link, 
however, is unknown. It could be that those with mental health problems smoke to 
reduce the negative affect that they experience as a result of their disorder. 
Conversely, it could be that smoking contributes to the mental health disorder. There 
is also evidence to suggest that genetic factors contribute to both (Kendler et al., 
1993). Research also suggests that mental health disorders may be associated with the 
maintenance of smoking because of the more severe nicotine withdrawal symptoms 
experienced by individuals with mental health disorders (Breslau et al., 1992; Covey 
et al., 1990) 
The many negative consequences resulting from smoking have prompted 
many smoking cessation interventions to be developed. NR T have been found to be 
one of the most effective of these strategies (Silagy et al., 1994). However, they have 
also been associated with a high rate of relapse (Silagy et al.). NRT used in 
combinations and for extended periods of time have been found to be the most 
effective (Croghan et al., 2003; Fagerstrom et al., 1993; Steinberg et al., 2006). The 
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findings on the effectiveness of brief advice delivered by physicians are mixed. 
However, a constant finding is that the way the advice is delivered is an important 
determinant of how well the advice will be received (Butler et al., 1998; Stott & Pill, 
1990). Other smoking interventions that have been found to be effective are the 
banning of smoking in certain areas, and proactive counselling as an adjunct to 
minimal interventions for younger light smoking male individuals (Fitchenburg & 
Glantz, 2002; Pan, 2006). An individual's level of nicotine dependence, as well as 
their socioeconomic status, has also been found to be related to how successful an 
individual will be at quitting smoking (Foulds et al., 2006). 
Although rates of smoking have declined in developed countries, there has 
been no decline in smoking amongst people with substance use disorders (Kalman, 
1998). Treating smoking in this population is important because the evidence suggests 
that the majority of these people will die from smoking-related illnesses and not from 
alcohol or other drugs (Hser et al., 1994; Hurt et al., 1996). Although it is commonly 
believed that attempting to address smoking with these individuals could jeopardise 
effective drug treatment, the majority of evidence suggests otherwise (Bobo et al., 
1998; Martinet al., 1997; Burling et al., 1991). In fact, there is evidence to suggest 
that treating these individual's smoking may actually improve outcomes with other 
drugs (Bobo et al.). 
The stages of change model theorises that a smoker is in one of the five stages 
of change at any one time (Prochaska & Velicer, 1997). In addition, as an individual 
moves through the five stages of change, they use a number of different processes of 
change to help them progress through the stages. There exists a large body of research 
supporting the stages of change model for smoking and other behaviours (Acton et al., 
2001; Brogan et al., 1999; Diclemente et al., 1991; Pearlman et al., 2004; Prochaska et 
Smoking, Mental Health, and AOD Treatment 23 
al., 2001 ). Characteristics of individuals in the different stages have been reported by 
research as well as the different processes that are used by individuals in the different 
stages. 
To date, there appears to be a paucity of research regarding stages of change 
and smoking amongst people attending alcohol and other drug treatment. It may be 
that the better alcohol and other drug abstinence rates found in those who ceased 
smoking could be related to the processes that these individuals use whilst ceasing 
smoking and maintaining smoking cessation. These processes would likely help an 
individual to stay abstinent from other drugs. It may also be that when these people 
are entering for alcohol and other drug treatment they are already in the stage of 
preparation or even maintenance (if they have already been abstinent for a period of 
time) which may be transferred to their tobacco use as well as their other drug or 
drugs. With the rates of smoking as high as they are in this population, addressing 
smoking for these individuals' remains a very important issue in public health and 
further research in this is necessary. 
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Depression and Stress in a Therapeutic Community for Alcohol and other Drug 
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Abstract 
Smoking is the largest single risk factor for premature death in developed countries. 
The research suggests that there are also relationships between smoking and 
symptoms of anxiety, depression and stress. The rates of smoking are much higher 
amongst individuals with substance use disorders than that of the general community 
yet smoking cessation is rarely offered in drug treatment programs. The present study 
aimed to test the relationship between nicotine dependence and symptoms of anxiety, 
depression and stress in a Therapeutic Community (TC) for alcohol and other drug 
rehabilitation. Participants were 30 people who were residents of a TC for alcohol and 
other drug rehabilitation. A correlational research design was utilised to test the 
relationships between the variables. A oneway ANOVA was also utilised to determine 
whether entering the TC for dependence on alcohol alone or alcohol and/or other 
drugs had an influence on participants symptoms of anxiety, depression and stress. A 
descriptive design was used to analyse self-report survey data. Three questionnaires 
were used to gather the data. A significant moderate positive correlation was found 
between nicotine dependence and stress. No significant main effects were found from 
the ANOV A. The results from the study support past research that suggests that 
smoking is associated with stress. Support was also provided for the "stages of 
change" model. If introduced into the TC, smoking interventions could initially 
involve education aimed at moving clients through the stages of change before 
offering smoking cessation. 
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The Relationship between Nicotine Dependence and Symptoms of Anxiety, 
Depression and Stress in a Therapeutic Community for Alcohol and other Drug 
Rehabilitation 
Introduction 
Smoking is the largest single risk factor for premature death in developed 
countries (WHO, 2007). In addition, the relationship between smoking tobacco and 
chronic health problems is well established (Bergen & Caporaso, 1999). Various 
health problems such as cancer of the lungs, oesophagus, cervix, anus, throat and 
bladder, as well as an increased risk ofheart disease and stroke are only some of the 
problems associated with smoking (Ryder Salmon & Walker, 2001). Less appears to 
be known about the relationships between smoking and mental health problems. 
Nonetheless, the rates of smoking have been found to be higher amongst psychiatric 
patients than in the general community (Hughes, Hatsukami, Mitchell, Dahlgren, 
1986). Smoking has also been found to have strong associations with depression 
(Kinnunen, Haukkala, Quiles, Spiro & Garvey, 2006; Williams & Ziedonis, 2004), 
anxiety (West & Hajek, 1997) and stress (Parrot, 1993). 
Tobacco contains the CNS stimulant nicotine (Ryder et al., 2001). Nicotine 
increases the levels of the neurotransmitter dopamine in the part of the brain that 
regulates feelings ofpleasure (Epping-Jordan, Watkins, Koob & Markou, 1998). It 
has been found to contribute to dependence, resulting in physical and neurobiologic 
withdrawal symptoms on cessation (Epping-Jordan et al., 1998). 
Mental Health Effects of Smoking 
There appears to be relationships between the amount an individual smokes 
and anxiety and depression. In a study that looked at relationships between smoking 
and anxiety and depression in teenagers, it was found that participants who reported 
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high levels of depression and anxiety were twice as likely to be smokers after 
controlling for potential confounds (Patton et al., 1996). Moreover, regular smokers 
were almost twice as likely as occasional smokers to report high levels of anxiety and 
depressive symptoms. This finding indicates that there may be relationships between 
level of nicotine dependence and anxiety and depression. Goodman and Capitman 
(2000) also found that current tobacco use among teenagers was a powerful 
determinant of developing a high level of depressive symptoms. 
In addition to depression and anxiety, smoking has also been found to be 
associated with more pervasive mental health disorders. Heavy smoking of tobacco 
during adolescence has been associated·with an increased risk of developing 
agoraphobia, generalised anxiety disorder, and panic disorder during early adulthood 
(after controlling for age, gender, difficult childhood temperament, alcohol and other 
drug use, anxiety and depressive disorders during adolescence, parental smoking, 
educational level, and psychopathology) (Johnson et al., 2000). Moreover, when 
asked to describe their changes in smoking behaviour and feeling states over the 
previous two years, adolescents reported an increase in affective distress with the 
progression from experimental to more regular smoking (Hirschman, Leventhal & 
Glynn, 1984). The first results from the 2007 National Drug Strategy Household 
Survey (NDSHS) also found that daily smokers were more likely than other recent 
smokers or non-smokers to report high or very high levels of psychological distress 
(AIHW, 2007). 
It is a commonly held belief amongst smokers that smoking relieves tension 
and stress (Ikard, Green & Horn, 1969). However, a closer look at the processes that 
occur in the smoker suggest otherwise. In a study by Parrot (1993) it was found that 
although smokers experienced a self-reported decrease in stress after smoking 
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cigarettes, they experienced higher general levels of stress than non-smokers. It was 
also found that after smoking cessation, smokers' general levels of stress were 
reduced. When queried about their moods over the day, smokers have reported 
patterns of repetitive mood fluctuations, with normal moods during cigarette smoking 
followed by increasing stress periods between cigarettes (Parrot, 1994a; Parrot, 
1994b). In addition, these mood fluctuations are more prominent in more dependent 
smokers, who also report mood control as the main reason for the maintenance of 
their smoking (Parrot, 1994b ). It has also been found that smokers' stress levels are 
similar to non smokers only whilst smoking and become worse during periods of 
abstinence (Parrot & Garnham, 1998). The repeated occurrence of elevated stress 
levels between cigarettes suggests that smokers experience above average daily stress 
levels. These findings suggest that smoking may contribute to increased stress levels 
in smokers. 
The research on smoking cessation and stress also suggests smoking 
contributes to stress levels. In a study that monitored smokers who were attempting to 
quit unaided over six months, Cohen and Lichtenstein (1990) found that the smokers 
who failed to quit reported unchanging levels of high stress at every follow-up 
session. Contrastingly, the former smokers who completely abstained from smoking 
during the six months reported a steady decrease in stress over time. These findings 
were made all the more important by the fact that both the successful and 
unsuccessful quitters reported similar stress levels at baseline, so it was not just the 
less stressed smokers who successfully quit. Other research has also found reduction 
in stress levels of former smokers after cessation (Carey, Kalra, Carey, Halperin & 
Richards, 1993; Parrot, 1995). The apparent high stress levels of smokers may 
adversely affect their success when they engage in smoking cessation interventions. 
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Smoking Cessation Interventions 
Due to the many negative consequences associated with smoking, such as an 
increased risk for both physical and mental illness including increased stress, many 
smoking cessation intervention strategies have been developed throughout the years. 
Nicotine replacement therapies (NRT) work by replacing the nicotine delivered by 
cigarettes so as to reduce the negative affect associated with nicotine withdrawal 
(Gold, Ruby & Harvey, 2002). In a meta-analysis on the efficacy ofNRT for smoking 
cessation conducted by Silagy, Mant, Fowler and Lodge (1994), it was found that 
NRTwere effective in aiding smoking cessation. However, all forms ofNRT were 
associated with a high relapse rate suggesting that minimising relapse is important if 
long-term smoking cessation is to be maintained. Other studies have shown NRT as 
well as bupropion hydrochloride (referred to bupropion) as being one of the most 
effective smoking cessation strategies (Gold et al.; Jorenby, 2001). Bupropion is an 
anti-depressant that works on the central nervous system to reduce the withdrawal 
symptoms during smoking cessation (Gold et al.). 
There is also evidence to suggest that using combinations of medications for 
smoking cessation can be effective. Some studies have shown combinations ofNRT 
to be more effective when compared with an NRT on its own (Croghan et al., 2003; 
Fagerstrom, Schneider & Lunell, 1993). A study by Steinberg, Foulds, Richardson, 
Burke and Shah (2006) which assessed the efficacy of combinations of medications 
for smoking cessation found that the use of combinations of medications was 
associated with a higher probability of remaining abstinent. Although this trend 
reduced somewhat over time, a six month follow-up indicated that it was continuing. 
Interestingly, those who received combinations of medications were assessed as being 
more nicotine dependent at the beginning of the study, but they still did as well as less 
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dependent smokers at both follow-ups. Steinberg et al. also found that longer duration 
of medication use was associated with better outcomes. It was found that those who 
continued to use medications had considerably better abstinence rates at six months. 
In recent years, doctors have been encouraged to routinely offer smoking 
cessation advice to all presenting patients who are smokers (Mullins, Livingston & 
Borland, 1999; Murray et al., 2008). The findings on the effectiveness of this 
approach are mixed. Murray et al. found that proactively identifying smokers who 
wanted to quit in primary care populations and referring them to a cessation service 
increased contacts with cessation services and the number of quit attempts. However, 
it was found that at the population level there was no significant impact on actual quit 
rates or reported cigarette consumption. Hajek, Taylor and Mills (2002) found that a 
single session brief intervention to prevent cardiac inpatients from returning to 
smoking after discharge was ineffective. The researchers concluded that single session 
brief interventions are insufficient to influence highly dependent smokers to quit. 
Factors Affecting Intervention Success 
Socioeconomic status has been found to be a predictor of success at smoking 
cessation. Foulds et al. (2006) found that participants with only a high school 
education were significantly less likely to have remained abstinent at both follow-up 
periods compared with participants who had a university degree. In addition, being 
unemployed predicted a poor outcome at four weeks follow-up, and not having 
private health insurance predicted a poor outcome at 26 week follow-up. The 
researchers suggested that the effect of socioeconomic background on outcomes is a 
result of the social environment of those with a lower socioeconomic background. For 
example, those with a lower socioeconomic background are less likely to work in 
smoke-free environments and are more likely to have friends and family who smoke. 
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Socioeconomic status and education level has also been found to be a predictor of 
smoking. Research has found rates of smoking to be higher amongst people with a 
lower educational background when compared to people with a higher educational 
background (Blakey & Wilson, 2005). A study by Kestila et al. (2006) found that 
young adults in the lowest educational category had a much higher risk of developing 
daily smoking than those in the highest educational category. 
The "stages of change" model was developed from observations of how 
people quit smoking on their own and has proven to be effective in the development 
of smoking cessation interventions (Prochaska, DiClemente, Velicer & Rossi, 1993). 
The five stages can have a bearing on how successful an individual will be at quitting 
smoking or changing any other kind of behaviour (Prochaska & Velicer, 1997). The 
stages are precontemplation, contemplation, preparation, action, and maintenance. 
People in the precontemplation stage are not intending to quit smoking in the near 
future, usually measured as the next six months. Individuals in the precontemplation 
stage may be underinformed of the full extent of the consequences of their behaviour 
or may be demoralised after failed attempts at behaviour change in the past. 
Precontemplators are resistant and are not ready for any interventions. People in the 
contemplation stage are intending to quit in the next 6 months. They are more aware 
of the benefits of changing their behaviour than people in precontemplation but are 
also very aware of the costs. People in contemplation seem to be in a state of 
ambivalence and can be in the contemplation stage for a very long time. They are 
typically not ready for action-oriented interventions. People in the preparation stage 
are intending to quit in the immediate future; usually measured as in the next 30 days. 
Generally these people have taken some form of action over the past year such as 
having sought counselling, consulted their physician, or bought a self-help book, and 
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also have a plan of future action. People in the action stage have stopped smoking 
within the last 6 months. When the model is applied to smoking, only complete 
abstinence qualifies as being action. Simply cutting down on the number of cigarettes 
or switching to lower tar or nicotine brands does not qualify as being action. This is 
because there is no safe level of use for tobacco (WHO, 2007). People in the 
maintenance stage are in the process of preventing relapse but do not have to focus on 
maintaining their change as much as those in action. It is estimated that people can be 
in the maintenance stage for anywhere between six months and five years. The 
"stages of change" model is a commonly used model in the addictions and public 
health field and is supported by a large body of research (Brogan, Prochaska and 
Prochaska, 1999; DiClemente et al., 1991; Pearlman, Wernicke, Thorndike and 
Haaga, 2004; Prochaska et al., 1994; Prochaska, Velicer, Fava, Rossi and Tsoh, 
2001). 
Smoking Interventions and Alcohol and Other Drug Treatment 
Due to many factors, such as the increased awareness ofthe health 
consequences associated with smoking as well as interventions such as banning 
smoking in public places, smoking has declined in developed countries in recent years 
(WHO, 2007). Despite this, there has been no significant reduction in smoking among 
individuals with substance use disorders (Kalman, 1998). The rates of smoking among 
individuals with substance use disorders have been found to be double to triple that of 
the general community (Batel, Pessione, Maitre & Rueff, 1995). In addition, many of 
the individuals that are successfully treated for their drug dependencies will 
experience a reduced quality of life and longevity due to smoking (Hurt et al., 1996). 
Indeed it is tobacco (not alcohol or illicit drugs) that has been found to be the leading 
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cause of death among former patients of a community addictions treatment program 
(Hurt et al.). 
Many drug treatment counsellors discourage clients from quitting smoking in 
early stages of recovery (Brigham, Schroeder & Schindler, 2007). One reason that 
smoking cessation is not advocated by drug treatment programs is that there is a 
concern that this could deter some individuals who are willing to address their 
substance use problem but not their smoking (Bobo, Mcilvain, Lando, Walker & 
Leed-Kelly, 1998). Another reason is the belief that encouraging smoking cessation 
during drug treatment could jeopardise effective treatment (Campbell, Wander, Stark 
& Holbert, 1995). Contrary to this commonly held belief, the research suggests that 
smoking cessation does not risk successful substance use treatment. A study by 
Martinet al., (1997) in which 205 recovering alcoholics were assigned to one of three 
smoking cessation groups found that at 12-month follow-up, only four percent of all 
participants had relapsed to use alcohol or other drugs. However, the lack of a non 
smoking cessation control group limited the study. Further support for these findings 
came from a study conducted by Burling, Marshall and Seidner (1991) in which 39 
inpatient alcohol dependent men were randomly assigned to a tobacco intervention or 
waitlist control group. No adverse effect on treatment was found for the tobacco 
intervention group as compared to the waitlist control group. In addition, Bobo et al. 
(1998) from their study of a randomised community intervention involving 575 
individuals from 12 residential treatment programs had a primary finding that urging 
alcohol dependant individuals to quit smoking is safe, even in early stages of 
recovery. No adverse effect was detected on participants being able to remain 
abstinent after treatment discharge. It was actually found that the likelihood of 
remaining abstinent for those who were repeatedly encouraged to quit smoking was 
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almost twice that of the control group over the one year follow-up. The researchers 
attributed the more favourable outcomes for those exposed to the tobacco intervention 
to a number of factors. It was likely that some of the aspects from the tobacco 
counselling reinforced key elements of effective alcohol treatment. In addition, the 
counselling sessions encouraged personal responsibility and supported a drug-free 
lifestyle, messages which may have generalised to alcohol use. The study was limited 
by the fact that all study data, apart from the analysis of saliva samples, were gathered 
via self-report. However, the researchers suggested that was unlikely to bias their 
primary finding as they were unable to detect evidence of differential reporting 
between intervention and control groups. This is an interesting finding and is contrary 
to what is believed throughout the addictions field. 
Smoking in the Therapeutic Community for Alcohol and Other Drug Treatment 
Whilst there is a large amount of existing research regarding the association 
between smoking, stress, anxiety and depression, as well as on the various smoking 
cessation strategies, to date there appears to have been little research conducted on 
these issues involving residents of a Therapeutic Community (TC) for alcohol and 
other drug (AOD) rehabilitation. Research suggests that smoking contributes to high 
stress levels (Parrot, 1993), anxiety (West & Hajek, 1997), and depressive symptoms 
(Kinnunen et al., 2006; Williams & Ziedonis, 2004). Therefore, determining whether 
smoking is contributing to these mental health problems in such a population could 
aid in the treatment of these individuals by giving reason to incorporate smoking 
reduction education and possibly smoking cessation strategies appropriate to 
individuals' progress in the rehabilitation program. Knowledge that smoking cessation 
may reduce such unpleasant symptoms could also provide motivation for residents 
living in the TC to stop or reduce their smoking. In addition, determining residents' 
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stages of change (Prochaska & Velicer, 1997) and past or current experience with 
smoking cessation may also contribute to the development of effective smoking 
cessation strategies. In the proposed study, the relationships between nicotine 
dependence and symptoms of anxiety, depression and stress will be examined. 
Therefore, the research question that will be tested is: Do symptoms of anxiety, 
depression and stress increase as nicotine dependence increases? It is hypothesised 
that as the level of nicotine dependence increases, symptoms of anxiety, depression 
and stress will also increase. If nicotine contributes to affective distress, as the 
research suggests, then it may be that the more drugs individuals uses the more 
affective distress they experience. Therefore, the second research question to be tested 
is: does having entered the TC for dependence on alcohol alone or alcohol and/or 
other drugs have an influence on participants' symptoms of anxiety, depression and 
stress? It is hypothesised that those who have entered the TC for dependence on 
alcohol and/or other drugs will score higher on measures on anxiety, depression and 
stress than those who have entered the TC for dependence on alcohol alone. In 
addition, participants' stages of change regarding smoking will be determined, as well 
as their views, motivations, and past experiences regarding smoking cessation. This 
information will assist Cyrenian House to make decisions about smoking cessation 
interventions appropriate for its clients. 
Method 
Design 
The present study utilised a correlational research design to test the 
relationship between nicotine dependence and symptoms of anxiety, depression and 
stress. In addition, Crosstabs were also used to describe the relationships between the 
non continuous variables and the continuous and non continuous variables. 
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Questionnaires were used to measure the variables. A descriptive design was used to 
analyse exploratory self-report survey data. 
Materials 
Three questionnaires were completed by the participants. The first 
questionnaire consisted of demographic questions and some questions regarding 
views, motivations, and past smoking cessation experiences (see Appendix A). The 
second questionnaire was the Fagerstrom Test for Nicotine Dependence (FTND) 
(Heatherton, Kozlowski & Frecker, 1991) (see Appendix B) and the third 
questionnaire was the Depression, Anxiety and Stress Scale (DASS) (Psychology 
Foundation of Australia, 2006) (see Appendix C). An information sheet (see 
Appendix D) was presented to the participants prior to administering the 
questionnaires. 
Fagerstrom Test for Nicotine Dependance 
The FTND is a self-report scale consisting of six questions with at least two 
possible answers for each question. Each answer has a corresponding score. The total 
score is calculated at the end which then gives an indication of an individual's level of 
nicotine dependence. There are five levels of nicotine dependence that an individual 
can fall into: very low dependence, low dependence, medium dependence, high 
dependence, and very high dependence. The FTND has been validated for adult 
populations and has acceptable construct validity, test-retest reliability, and internal 
consistency (Fauzia, 2005). 
Depression Anxiety and Stress Scale 
The DASS consists of a set of three self-report scales designed to measure the 
emotional states of depression, anxiety and stress. It is a 42-item scale in total, with a 
4-point Iikert response format measuring the severity/frequency to which an 
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individual has experienced certain states over the past week. Each of the three scales 
contains 14 items which are divided into subscales of2-5 items with similar content. 
The scales of the DASS have been found to have high internal consistency and to 
yield meaningful discriminations in a variety of settings (Psychology Foundation of 
Australia, 2006). 
Participants 
The participants were 30 adults aged 18 years or older, who were living in a 
TC for alcohol and other drug rehabilitation. 
Procedure 
The proposed research was conducted with the assistance and approval of 
Cyrenian House Therapeutic Community (see Appendix E). In addition, the research 
had Edith Cowan University ethics clearance. Residents were given the information 
sheet outlining the nature and purpose of the research (see Appendix D), and were 
then given a package containing the three questionnaires which took approximately 30 
minutes to complete. A box was provided for residents to place completed 
questionnaires into over the next week and they were informed of the researcher's 
availability to answer any questions or help with any problems they might encounter. 
Residents were informed that participation was not compulsory and that they would 
be able to withdraw from the study at any time without prejudice. In addition, all 
participants remained anonymous. 
Correlation Analysis 
The questionnaire data was entered into SPSS for Windows (Version 12.0), 
(Coakes, 2005) and a Pearson product-moment correlation coefficient (Pearson's r) 
was conducted between the level of nicotine dependence and levels of anxiety, 
depression and stress. This allowed for any relationship among the variables to be 
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identified. In addition, Cross tabulations using Spearman Rho were performed 
between the non continuous variables, and the continuous and non continuous 
variables. 
Results 
The intercorrelations of all the variables are shown in Table I along with the 
means and standard deviations of the continuous variables. There were no significant 
correlations found between nicotine dependence and anxiety and depression. A 
moderate significant positive correlation was found between nicotine dependence and 
stress. There was a significant moderate positive correlation found between 
participants' stage of change and whether they want to smoke. There was also a 
significant moderate-to-strong positive correlation found between participants' stage 
of change and how much entering the TC motivated them to quit smoking. In 
addition, there was a significant strong negative correlation found between 
participants' stage of change and whether they would use quit support if it was offered 
to them during their stay in the TC. A significant moderate positive correlation was 
also found between participants' age of first cigarette used and participants' age of 
first smoking daily. Moreover, significant moderate positive correlations were found 
between education and participants' age of first cigarette and participants' age of first 
smoking daily. Additionally, there was also a significant weak positive correlation 
found between education and having ever smoked. 
Group Comparison Analysis 
A oneway analysis ofvariance (ANOVA) was conducted using SPSS for 
Windows (Versionl2.0) to determine the influence of whether participants drug of 
choice influenced their anxiety, depression and stress scores. The main effect for 
depression was not significant, F(l, 29) = O.Ol,p > .05. The main effect for anxiety 
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was not significant, F(l, 29) = 0.46,p > .05. The main effect for stress was also not 
significant, F(l, 29) = 0.59,p > .05. 
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Discussion 
The present study aimed to test the research question: Do symptoms of anxiety, 
depression and stress increase as nicotine dependence increases? It was hypothesised that 
as the level of nicotine dependence increases, symptoms of anxiety, depression and stress 
will also increase. The findings of the present study only partially support the hypothesis. 
There was a moderate significant positive relationship found between nicotine 
dependence and stress. This finding is consistent with previous research that has shown 
that smoking actually exacerbates stress and that more dependent smokers are more 
stressed (Parrot & Garnham, 1998; Parrot, 1993; Parrot, 1994a; Parrot, 1994b). Previous 
research has found that, contrary to commonly held beliefs in the addictions field, 
smoking cessation amongst people in alcohol and other drug treatment does not 
jeopardise their treatment and has actually shown to improve treatment outcomes (Bobo 
et al., 1998; Martinet al., 1997; Burling et al., 1991). The present study showed that the 
more nicotine dependent individuals were in the TC, the more likely they were to have 
higher stress levels. Previous research has shown that ceasing smoking actually results in 
a decrease in stress levels for the abstaining smoker (Carey et al., 1993; Cohen and 
Lichtenstein, 1990; Parrot, 1995). Therefore, ifthe residents were ceasing smoking 
during their stay in the TC they may have lower stress levels and consequently may be 
better equipped to achieve successful treatment outcomes. 
Previous research has found that the more dependent an individual is on nicotine, 
the more they will report they rely on smoking for stress release (Parrot, 1994b ). The 
present study supports this research. There was a significant moderate negative 
relationship found between nicotine dependence and whether an individual thinks that 
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smoking decreases their stress levels. This indicated that the more dependent participants 
were on smoking, the more likely they were to answer 'yes' to the whether they think 
smoking decreases their stress levels. All the participants apart from one who scored five 
or more on the nicotine dependence scale said they thought smoking decreases their 
stress levels. In contrast, out of the five people who scored less than five on the nicotine 
dependence scale, only two answered 'yes' and three answered 'no'. In addition to this, 
there was a significant moderate relationship found between participants' age of first 
smoking daily and whether they think smoking decreases their stress levels. This 
indicates that the younger participants were when they started smoking daily, the more 
likely they are to rely on smoking for stress release, suggesting that they are generally 
more stressed. 
Although there was a relationship found between nicotine dependence and stress, 
there were no significant relationships found between nicotine dependence and 
depression and anxiety. It is unclear why there was no relationship between nicotine 
dependence and anxiety or depression. One possible explanation is that much of the 
education that is delivered in the TC is based on cognitive-behavioural therapy (CBT), 
which teaches techniques around reducing these symptoms. The lower scores for anxiety 
and depression in comparison to stress could be attributable to the residents using CBT 
effectively. In addition to this, it could also be that the participants in the TC were in a 
positive frame of mind because their lives are heading in a better direction by being a part 
of the TC, therefore reporting lower depressive and anxiety symptoms. 
The non significant results from the ANOV A indicate that there was not a 
significant difference between the anxiety, depression and stress scores of people who 
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had entered the TC dependent on alcohol and people who were dependent on alcohol 
and/or other drugs. Nonetheless, the present study demonstrated that the residents of the 
TC in general, experience higher levels of affective distress than that of the general 
population. The means from a sample of 2914 adults from the general population on 
measures of depression, anxiety, and stress were 6.34, 4.70, and 10.11 respectively 
(Lovibond & Lovibond, 1995). The means for depression, anxiety and stress from the 
present study were 13.43, 12.33, and 17.63 respectively. The mean for depression fell 
into the mild category, the mean for anxiety fell into the moderate category and the mean 
for stress fell into the mild category. Stress scores were the highest out of the three 
scores. This is consistent with the measure with the cut-offs for the different categories 
being the highest for stress followed by depression and then anxiety. 
Previous research has found rates of smoking among individuals with substance 
use disorders to be double to triple that of the general community (Batel, Pessione, Maitre 
& Rueff, 1995). The first results ofthe NDSHS revealed that in 2007, 16.6% ofthe 
population aged 14 years or older reported smoking daily (AIHW, 2007). The present 
study found that 90% of participants were smoking daily. Although the participants in the 
present study were aged 18 years or older and the population included in the NDSHS 
were aged 14 years or older, this finding is still important and supports past research that 
has suggested that the rates of smoking are much higher amongst individuals with 
substance use disorders than that of the general community. 
Support for the "stages of change" theory came from the present study. There was 
a significant moderate positive relationship found between participants' stage of change 
and whether they want to smoke presently. This indicates that the participants in the 
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earlier stages of change were more likely to want to smoke and the participants in the 
later stages of change were less likely to want to smoke, supporting the concept that when 
people are in precontemplation they can be regarded as 'happy users' (Prochaska & 
Velicer, 1997). In addition, there was a significant strong positive relationship between 
participants' stage of change and how much entering the TC motivated them to quit 
smoking. This indicates that for the individuals in the early stages of change, entering the 
TC was less likely to motivate them to quit smoking, and for the individuals in the later 
stages of change, entering the TC was more likely to motivate them to quit smoking. 
Furthermore, there was a significant strong negative relationship found between 
participants' stage of change and whether they would use quit support if it was offered to 
them during their stay in the TC. This indicates that the participants in the later stages of 
change were much more likely to utilise quit support if offered to them during their stay 
in the TC. These findings support the idea that people in the later stages of change are 
more consciously thinking about quitting smoking and are consistent with previous 
research regarding the stages of change theory (Brogan, Prochaska and Prochaska, 1999; 
DiClemente et al., 1991; Pearlman, Wernicke, Thorndike and Haaga, 2004; Prochaska et 
al., 1994; Prochaska, Velicer, Fava, Rossi and Tsoh, 2001). 
Although weak, a significant negative relationship was found between 
participants' stage of change and nicotine dependence. This indicated that participants in 
the later stages of change tended to have lower scores on the nicotine dependence scale 
suggesting that it may be easier for these individuals to be thinking about or planning on 
quitting if their nicotine dependence is not so high. The relationship may also be a result 
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of these individuals smoking less in preparation for quitting smoking and therefore 
having a lower level of nicotine dependence. 
There was a significant moderate positive relationship found between age of first 
cigarette and age of starting smoking daily. This finding indicates that the older 
participants were when they tried their first cigarette, the older they were when they 
started smoking daily. For example, a large proportion of the participants that tried their 
first cigarette between ages 10-14, started smoking daily between ages 14-18. There was 
also a weak significant negative relationship found between age of starting smoking daily 
and stress, as well as a weak significant negative relationship found between age of 
starting smoking daily and anxiety. This indicates that as age of starting smoking daily 
increases, stress and anxiety decreases. Therefore, the younger participants were when 
they had taken up smoking regularly, the more likely they were to have high stress and 
anxiety levels presently. This is in line with previous research that suggests that taking up 
regular smoking at a young age can have worse mental health outcomes than taking up 
regular smoking at an older age (Hirschman et al., 1984; Johnson et al., 2000). Further 
supporting these findings was the significant moderate positive relationship found 
between participants' age of starting smoking daily and whether they think that smoking 
decreases their stress levels. This relationship indicates that the older participants were 
when they started smoking daily the more likely they were to report that they do not think 
that smoking decreases their stress levels. These findings highlight the importance of 
preventing youth from experimenting with smoking. 
Research has found socioeconomic status and education level to be a predictor of 
smoking, as well as a predictor of success at smoking cessation (Blakey & Wilson, 2005; 
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Foulds et al., 2006; Kestila et al., 2006). The findings from the present study support 
previous research. Significant moderate positive relationships were found between 
education and participants' age of first cigarette use and age of first smoking daily, 
indicating that the higher the level of education obtained by participants, the older they 
were more likely to be when they tried their first cigarette and when they started smoking 
daily. In addition, there was also a significant weak positive correlation found between 
education and participants having ever smoked, indicating that the higher the level of 
education obtained by participants, the less likely they were to have ever smoked. This 
could also be seen from screening the data: both never smokers being two of only five 
participants who had university degrees. Interestingly, in addition to this, one ofthe other 
three participants that had a university degree only had a score of one on the nicotine 
dependence scale. Previous research has suggested that the effect of socioeconomic 
background on smoking is a result ofthe social environment of those with a lower 
socioeconomic background (Foulds et al., 2006). For example, those with a lower 
socioeconomic background are less likely to work in smoke-free environments and are 
more likely to have friends and family who smoke. This is likely the case for the present 
study. 
Previous research has shown NRT to be an effective strategy to assist people to 
quit smoking (Gold et al., 2002; Jorenby, 2001; Silagy et al., 1994). The findings from 
the present study further support past research. It was found that of the 13 people that had 
used NRT in the past, nine of those found NRT to be effective in helping to quit smoking. 
However, all of these individuals were currently smoking so therefore the NRT did not 
have a lasting effect which is also consistent with previous research (Silagy et al.). The 
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next most common strategy that people had used in the past was asking their doctor for 
help to quit. However, of the seven people who did this only three said that it had been 
effective. This is also in line with previous research that has found brief interventions 
delivered by doctors to be ineffective in helping people to quit (Hajek et al., 2002; 
Murray et al., 2008). 
Participants were also asked what had motivated them to quit smoking in the past. 
The most common answers were 'it was costing too much money', 'I wanted to get fit', 
'it was affecting my fitness', as well as 'I was pregnant or wanting to start a family'. 
These answers were markedly more frequent than the health warnings or quit 
advertisements on TV answers. This information could be useful in the development of 
strategies to motivate people to quit smoking. 
When asked why they don't intend to quit the most frequent answer given by 
participants was 'I am addicted to nicotine' followed closely by 'I enjoy smoking' and 
'smoking relaxes me'. This is consistent with previous research that has found that 
smokers indicate that smoking relaxes them and that they enjoy smoking (Ikard et al., 
1969). This further supports the concept that smoking contributes to stress levels in the 
smoker, in that their general stress levels are higher and smoking brings their stress levels 
back to the same as a non smoker's general stress levels (Parrot, 1993; Parrot, 1994a; 
Parrot, 1994b). However, smoking is more likely to contribute to high stress levels than it 
is to relieving stress. Smokers probably perceive smoking to relieve their stress because 
they get relief almost immediately when they light a cigarette. But this relief is more 
likely to be related to nicotine levels in the blood being increased as soon as a cigarette is 
lit (i.e. with the first puff). So what smokers perceive as stress relief is actually relief 
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from the feeling they get when they have gone without a cigarette for a period oftime. 
This is a result of the physical dependence that occurs from nicotine use. 
Findings of importance for Cyrenian House include the finding regarding 
participants' views towards quit support. Of the participants that responded to the 
question, 48.1% indicated that they would use quit support if it were offered to them 
during their stay in the TC. This finding goes against the commonly held belief that 
people seeking AOD treatment are only interested in dealing with their AOD 
dependencies and do not want to address their smoking. The relationship found between 
participants' stage of change and whether they would use quit support also suggests that a 
large proportion ofthe other 51.9% who indicated that they would not use quit support 
are likely part ofthe 57.1% ofparticipants that were in precontemplation. Therefore, 
these individuals could be given education to move them into preparation and then could 
be offered quit support by way ofNRT. In addition, there was a significant moderate 
positive relationship found between whether participants want to smoke and how much 
entering the TC motivated them to quit smoking, indicating that the participants that 
reported not wanting to smoke were more likely to report that entering the TC motivated 
them to quit smoking. There was also a significant moderate negative relationship found 
between how much entering the TC motivated participants to quit smoking and whether 
they would use quit support if offered to them. This indicates that the participants who 
reported being motivated to quit smoking would be more likely to use quit support if it 
was offered to them. Moreover, a significant moderate positive relationship was also 
found between whether participants would use quit support if offered to them and the 
effect that having one smoking area in the TC would have on their smoking. This 
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indicates that those who reported that they would not use quit support were more likely to 
report that having one smoking area in the TC would reduce their smoking largely. 
Other noteworthy findings include the significant negative moderate relationship 
found between age and anxiety, indicating that the younger the participants were the 
more likely they were to have higher anxiety scores. Moreover, there was a significant 
negative moderate relationship also found between length of stay and anxiety, indicating 
that the less time participants had been residents of the TC the more likely they were to 
have higher anxiety scores. This finding stands to reason, in that people would be more 
anxious in their first few weeks of entering 'a rehabilitation program, whether from 
experiencing withdrawal symptoms or from adjusting to a foreign environment. 
There are some limitations with the present study. Firstly, all data was gathered 
via self-report so it could not be certain that participants answered all questions honestly. 
Secondly, participants in a residential drug rehabilitation setting are likely to experience 
negative affect due to withdrawal from alcohol and other drugs. This may have 
influenced the participants' scores on the DASS instrument. Finally, a sample size of 
more than 30 participants would have been desirable. However, there are normally only 
25 to 30 residents staying in the TC at any one time and due to the unique nature of the 
setting it was not feasible to recruit participants from other residential rehabilitation 
centres. The fact that all participants were from Cyrenian House TC was also a strength 
of the present study. The findings may inform Cyrenian House as to the most appropriate 
action to undertake regarding smoking cessation and intervention. Another strength of the 
study was the measure of the effect of nicotine on mental health. Most other studies on 
the effect of nicotine on mental health symptoms have not been conducted on individuals 
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living in a TC for alcohol and other drug rehabilitation. Residents of the TC are not 
permitted to use alcohol or other drugs that are not prescribed during their stay. In 
contrast, other studies would likely not have been able to control for their participants 
using alcohol or other drugs and therefore may have had results that were influenced by 
their participants using alcohol or other drugs. Therefore, in this sense, the present study 
is a more pure measure ofthe effect of nicotine on mental health. 
In conclusion, the findings from the present study suggest that smoking may be 
contributing to the TC residents' stress levels. Therefore, if smoking intervention can 
reduce symptoms of stress for residents it may result in better treatment outcomes. For 
those residents assessed as being in the early stages of change, interventions could focus 
on moving residents through the stages of change before incorporating smoking 
cessation. Interventions could include education around the negative health consequences 
of smoking as well as education around the less commonly known mental health 
problems associated with smoking. In addition, the education could also incorporate 
some stress management techniques. Residents assessed as being ready to change their 
smoking behaviour, along with residents who have received intervention, could be 
offered smoking cessation, with the aid ofNRT. This may result in lower symptoms of 
stress due to the fact they would be receiving a consistent amount of nicotine throughout 
the day instead of intermittent periods ofheavy smoking. To incorporate smoking 
intervention and cessation into the TC program and assess residents' symptoms of 
anxiety, depression and stress pre and post intervention and cessation would be a useful 
direction for future research. 
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Appendix A 
Please answer all questions that apply to you and use the tick boxes where provided. 
1. What is your age? 18-25 D 25-35 D 35-45 D over 45 D 
2. What is your sex? M D F D 
3. What is your level of formal education? (Please tick box, mark all that apply) 
finished primary school D finished year 10 at secondary school D 
finished year 12 at secondary school D completed TAFE course D 
completed university degree D oth~r D 
4. How long have you been living at Cyrenian House? 0-4 weeks D 4-8 weeks D 
8-12 weeks D 12-16 weeks D 16-20 weeks D over 20 weeks D 
5. What was your main drug of concern for entering Cyrenian House? Alcohol D 
cannabis D amphetamines D heroin D other opiates D benzos D 
6. Do you currently smoke cigarettes? Y D N D 
7. Have you ever smoked cigarettes? Y D N D (only continue if answer is yes) 
8. About what age were you when you smoked your first full cigarette? Under 6 D 
6-10 D 10-14 0 14-18 D over 18 D 
9. At what age did you first start smoking on a daily basis? Under 6 D 6-10 D 
10-14 D 14-18 D 18-25 D over 25 D 
10. During the last 12 months, did you find that you couldn't stop smoking, even though 
you want to or tried to? Y D N D 
11. During the last 12 months, did you find that you couldn't cut down on your smoking, 
even though you want to or tried to? Y 0 N D 
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12. Do you want to smoke now? Y 0 N 0 
13. In the past have you .... ? (tick all that apply) 
Given up smoking (for more than a month) 0 
Tried to give up unsuccessfully 0 
Changed to a brand with lower tar or nicotine content 0 
Tried to change to a brand with lower tar or nicotine content, but unsuccessfully 0 
Reduced the amount of tobacco you smoke in a day 0 
Tried to reduce the amount of tobacco you smoke in a day, but unsuccessfully 0 
None of these 0 (skip to question 20) 
14. Which of the following motivated you to try giving up, cutting down or changing to a 
lower tar or nicotine brand? (tick all that apply) 
Health warnings on cigarette packets 0 Quit advertisements on TV 0 
Quit advertisements on radio 0 Quit advertisements in newspapers etc 0 
Advertisements for nicotine replacement products eg nicotine gum, patches, Zyban 0 
QUIT line (phone number on cigarette packet) 0 
I wanted to get fit 0 I was pregnant or wanting to start a family 0 
I thought it was affecting my health or fitness 0 My doctor advised me to give up 0 
Family and/or friends asked me to quit 0 
I was worried it was affecting the health of those around me 0 
It was costing too much money 0 
Smoking bans in public areas (e.g. restaurants, sporting venues etc.) U 
Smoking bans at work 0 Other 0 
15. Do you plan on giving up smoking .... ? 
Not in the next 6 months 0 in the next 6 months 0 in the next month 0 
I quit smoking within the last 6 months 0 I quit smoking over 6 months ago 0 
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Discussion 
The present study aimed to test the research question: Do symptoms of anxiety, 
depression and stress increase as nicotine dependence increases? It was hypothesised that 
as the level of nicotine dependence increases, symptoms of anxiety, depression and stress 
will also increase. The findings of the present study only partially support the hypothesis. 
There was a moderate significant positive relationship found between nicotine 
dependence and stress. This finding is consistent with previous research that has shown 
that smoking actually exacerbates stress and that more dependent smokers are more 
stressed (Parrot & Garnham, 1998; Parrot, 1993; Parrot, 1994a; Parrot, 1994b). Previous 
research has found that, contrary to commonly held beliefs in the addictions field, 
smoking cessation amongst people in alcohol and other drug treatment does not 
jeopardise their treatment and has actually shown to improve treatment outcomes (Bobo 
et al., 1998; Martinet al., 1997; Burling et al., 1991). The present study showed that the 
more nicotine dependent individuals were in the TC, the more likely they were to have 
higher stress levels. Previous research has shown that ceasing smoking actually results in 
a decrease in stress levels for the abstaining smoker (Carey et al., 1993; Cohen and 
Lichtenstein, 1990; Parrot, 1995). Therefore, ifthe residents were ceasing smoking 
during their stay in the TC they may have lower stress levels and consequently may be 
better equipped to achieve successful treatment outcomes. 
Previous research has found that the more dependent an individual is on nicotine, 
the more they will report they rely on smoking for stress release (Parrot, 1994b ). The 
present study supports this research. There was a significant moderate negative 
relationship found between nicotine dependence and whether an individual thinks that 
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smoking decreases their stress levels. This indicated that the more dependent participants 
were on smoking, the more likely they were to answer 'yes' to the whether they think 
smoking decreases their stress levels. All the participants apart from one who scored five 
or more on the nicotine dependence scale said they thought smoking decreases their 
stress levels. In contrast, out of the five people who scored less than five on the nicotine 
dependence scale, only two answered 'yes' and three answered 'no'. In addition to this, 
there was a significant moderate relationship found between participants' age of first 
smoking daily and whether they think smoking decreases their stress levels. This 
indicates that the younger participants were when they started smoking daily, the more 
likely they are to rely on smoking for stress release, suggesting that they are generally 
more stressed. 
Although there was a relationship found between nicotine dependence and stress, 
there were no significant relationships found between nicotine dependence and 
depression and anxiety. It is unclear why there was no relationship between nicotine 
dependence and anxiety or depression. One possible explanation is that much of the 
education that is delivered in the TC is based on cognitive-behavioural therapy (CBT), 
which teaches techniques around reducing these symptoms. The lower scores for anxiety 
and depression in comparison to stress could be attributable to the residents using CBT 
effectively. In addition to this, it could also be that the participants in the TC were in a 
positive frame of mind because their lives are heading in a better direction by being a part 
of the TC, therefore reporting lower depressive and anxiety symptoms. 
The non significant results from the ANOV A indicate that there was not a 
significant difference between the anxiety, depression and stress scores of people who 
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had entered the TC dependent on alcohol and people who were dependent on alcohol 
and/or other drugs. Nonetheless, the present study demonstrated that the residents of the 
TC in general, experience higher levels of affective distress than that of the general 
population. The means from a sample of 2914 adults from the general population on 
measures of depression, anxiety, and stress were 6.34, 4.70, and 10.11 respectively 
(Lovibond & Lovibond, 1995). The means for depression, anxiety and stress from the 
present study were 13.43, 12.33, and 17.63 respectively. The mean for depression fell 
into the mild category, the mean for anxiety fell into the moderate category and the mean 
for stress fell into the mild category. Stress scores were the highest out of the three 
scores. This is consistent with the measure with the cut-offs for the different categories 
being the highest for stress followed by depression and then anxiety. 
Previous research has found rates of smoking among individuals with substance 
use disorders to be double to triple that of the general community (Batel, Pessione, Maitre 
& Rueff, 1995). The first results ofthe NDSHS revealed that in 2007, 16.6% ofthe 
population aged 14 years or older reported smoking daily (AIHW, 2007). The present 
study found that 90% of participants were smoking daily. Although the participants in the 
present study were aged 18 years or older and the population included in the NDSHS 
were aged 14 years or older, this finding is still important and supports past research that 
has suggested that the rates of smoking are much higher amongst individuals with 
substance use disorders than that of the general community. 
Support for the "stages of change" theory came from the present study. There was 
a significant moderate positive relationship found between participants' stage of change 
and whether they want to smoke presently. This indicates that the participants in the 
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earlier stages of change were more likely to want to smoke and the participants in the 
later stages of change were less likely to want to smoke, supporting the concept that when 
people are in precontemplation they can be regarded as 'happy users' (Prochaska & 
Velicer, 1997). In addition, there was a significant strong positive relationship between 
participants' stage of change and how much entering the TC motivated them to quit 
smoking. This indicates that for the individuals in the early stages of change, entering the 
TC was less likely to motivate them to quit smoking, and for the individuals in the later 
stages of change, entering the TC was more likely to motivate them to quit smoking. 
Furthermore, there was a significant strong negative relationship found between 
participants' stage of change and whether they would use quit support if it was offered to 
them during their stay in the TC. This indicates that the participants in the later stages of 
change were much more likely to utilise quit support if offered to them during their stay 
in the TC. These findings support the idea that people in the later stages of change are 
more consciously thinking about quitting smoking and are consistent with previous 
research regarding the stages of change theory (Brogan, Prochaska and Prochaska, 1999; 
DiClemente et al., 1991; Pearlman, Wernicke, Thorndike and Haaga, 2004; Prochaska et 
al., 1994; Prochaska, Velicer, Fava, Rossi and Tsoh, 2001). 
Although weak, a significant negative relationship was found between 
participants' stage of change and nicotine dependence. This indicated that participants in 
the later stages of change tended to have lower scores on the nicotine dependence scale 
suggesting that it may be easier for these individuals to be thinking about or planning on 
quitting if their nicotine dependence is not so high. The relationship may also be a result 
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of these individuals smoking less in preparation for quitting smoking and therefore 
having a lower level of nicotine dependence. 
There was a significant moderate positive relationship found between age of first 
cigarette and age of starting smoking daily. This finding indicates that the older 
participants were when they tried their first cigarette, the older they were when they 
started smoking daily. For example, a large proportion of the participants that tried their 
first cigarette between ages 10-14, started smoking daily between ages 14-18. There was 
also a weak significant negative relationship found between age of starting smoking daily 
and stress, as well as a weak significant negative relationship found between age of 
starting smoking daily and anxiety. This indicates that as age of starting smoking daily 
increases, stress and anxiety decreases. Therefore, the younger participants were when 
they had taken up smoking regularly, the more likely they were to have high stress and 
anxiety levels presently. This is in line with previous research that suggests that taking up 
regular smoking at a young age can have worse mental health outcomes than taking up 
regular smoking at an older age (Hirschman et al., 1984; Johnson et al., 2000). Further 
supporting these findings was the significant moderate positive relationship found 
between participants' age of starting smoking daily and whether they think that smoking 
decreases their stress levels. This relationship indicates that the older participants were 
when they started smoking daily the more likely they were to report that they do not think 
that smoking decreases their stress levels. These findings highlight the importance of 
preventing youth from experimenting with smoking. 
Research has found socioeconomic status and education level to be a predictor of 
smoking, as well as a predictor of success at smoking cessation (Blakey & Wilson, 2005; 
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Foulds et al., 2006; Kestila et al., 2006). The findings from the present study support 
previous research. Significant moderate positive relationships were found between 
education and participants' age of first cigarette use and age of first smoking daily, 
indicating that the higher the level of education obtained by participants, the older they 
were more likely to be when they tried their first cigarette and when they started smoking 
daily. In addition, there was also a significant weak positive correlation found between 
education and participants having ever smoked, indicating that the higher the level of 
education obtained by participants, the less likely they were to have ever smoked. This 
could also be seen from screening the data: both never smokers being two of only five 
participants who had university degrees. Interestingly, in addition to this, one ofthe other 
three participants that had a university degree only had a score of one on the nicotine 
dependence scale. Previous research has suggested that the effect of socioeconomic 
background on smoking is a result ofthe social environment of those with a lower 
socioeconomic background (Foulds et al., 2006). For example, those with a lower 
socioeconomic background are less likely to work in smoke-free environments and are 
more likely to have friends and family who smoke. This is likely the case for the present 
study. 
Previous research has shown NRT to be an effective strategy to assist people to 
quit smoking (Gold et al., 2002; Jorenby, 2001; Silagy et al., 1994). The findings from 
the present study further support past research. It was found that of the 13 people that had 
used NRT in the past, nine of those found NRT to be effective in helping to quit smoking. 
However, all of these individuals were currently smoking so therefore the NRT did not 
have a lasting effect which is also consistent with previous research (Silagy et al.). The 
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next most common strategy that people had used in the past was asking their doctor for 
help to quit. However, of the seven people who did this only three said that it had been 
effective. This is also in line with previous research that has found brief interventions 
delivered by doctors to be ineffective in helping people to quit (Hajek et al., 2002; 
Murray et al., 2008). 
Participants were also asked what had motivated them to quit smoking in the past. 
The most common answers were 'it was costing too much money', 'I wanted to get fit', 
'it was affecting my fitness', as well as 'I was pregnant or wanting to start a family'. 
These answers were markedly more frequent than the health warnings or quit 
advertisements on TV answers. This information could be useful in the development of 
strategies to motivate people to quit smoking. 
When asked why they don't intend to quit the most frequent answer given by 
participants was 'I am addicted to nicotine' followed closely by 'I enjoy smoking' and 
'smoking relaxes me'. This is consistent with previous research that has found that 
smokers indicate that smoking relaxes them and that they enjoy smoking (Ikard et al., 
1969). This further supports the concept that smoking contributes to stress levels in the 
smoker, in that their general stress levels are higher and smoking brings their stress levels 
back to the same as a non smoker's general stress levels (Parrot, 1993; Parrot, 1994a; 
Parrot, 1994b). However, smoking is more likely to contribute to high stress levels than it 
is to relieving stress. Smokers probably perceive smoking to relieve their stress because 
they get relief almost immediately when they light a cigarette. But this relief is more 
likely to be related to nicotine levels in the blood being increased as soon as a cigarette is 
lit (i.e. with the first puff). So what smokers perceive as stress relief is actually relief 
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from the feeling they get when they have gone without a cigarette for a period oftime. 
This is a result of the physical dependence that occurs from nicotine use. 
Findings of importance for Cyrenian House include the finding regarding 
participants' views towards quit support. Of the participants that responded to the 
question, 48.1% indicated that they would use quit support if it were offered to them 
during their stay in the TC. This finding goes against the commonly held belief that 
people seeking AOD treatment are only interested in dealing with their AOD 
dependencies and do not want to address their smoking. The relationship found between 
participants' stage of change and whether they would use quit support also suggests that a 
large proportion ofthe other 51.9% who indicated that they would not use quit support 
are likely part ofthe 57.1% ofparticipants that were in precontemplation. Therefore, 
these individuals could be given education to move them into preparation and then could 
be offered quit support by way ofNRT. In addition, there was a significant moderate 
positive relationship found between whether participants want to smoke and how much 
entering the TC motivated them to quit smoking, indicating that the participants that 
reported not wanting to smoke were more likely to report that entering the TC motivated 
them to quit smoking. There was also a significant moderate negative relationship found 
between how much entering the TC motivated participants to quit smoking and whether 
they would use quit support if offered to them. This indicates that the participants who 
reported being motivated to quit smoking would be more likely to use quit support if it 
was offered to them. Moreover, a significant moderate positive relationship was also 
found between whether participants would use quit support if offered to them and the 
effect that having one smoking area in the TC would have on their smoking. This 
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indicates that those who reported that they would not use quit support were more likely to 
report that having one smoking area in the TC would reduce their smoking largely. 
Other noteworthy findings include the significant negative moderate relationship 
found between age and anxiety, indicating that the younger the participants were the 
more likely they were to have higher anxiety scores. Moreover, there was a significant 
negative moderate relationship also found between length of stay and anxiety, indicating 
that the less time participants had been residents of the TC the more likely they were to 
have higher anxiety scores. This finding stands to reason, in that people would be more 
anxious in their first few weeks of entering 'a rehabilitation program, whether from 
experiencing withdrawal symptoms or from adjusting to a foreign environment. 
There are some limitations with the present study. Firstly, all data was gathered 
via self-report so it could not be certain that participants answered all questions honestly. 
Secondly, participants in a residential drug rehabilitation setting are likely to experience 
negative affect due to withdrawal from alcohol and other drugs. This may have 
influenced the participants' scores on the DASS instrument. Finally, a sample size of 
more than 30 participants would have been desirable. However, there are normally only 
25 to 30 residents staying in the TC at any one time and due to the unique nature of the 
setting it was not feasible to recruit participants from other residential rehabilitation 
centres. The fact that all participants were from Cyrenian House TC was also a strength 
of the present study. The findings may inform Cyrenian House as to the most appropriate 
action to undertake regarding smoking cessation and intervention. Another strength of the 
study was the measure of the effect of nicotine on mental health. Most other studies on 
the effect of nicotine on mental health symptoms have not been conducted on individuals 
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living in a TC for alcohol and other drug rehabilitation. Residents of the TC are not 
permitted to use alcohol or other drugs that are not prescribed during their stay. In 
contrast, other studies would likely not have been able to control for their participants 
using alcohol or other drugs and therefore may have had results that were influenced by 
their participants using alcohol or other drugs. Therefore, in this sense, the present study 
is a more pure measure ofthe effect of nicotine on mental health. 
In conclusion, the findings from the present study suggest that smoking may be 
contributing to the TC residents' stress levels. Therefore, if smoking intervention can 
reduce symptoms of stress for residents it may result in better treatment outcomes. For 
those residents assessed as being in the early stages of change, interventions could focus 
on moving residents through the stages of change before incorporating smoking 
cessation. Interventions could include education around the negative health consequences 
of smoking as well as education around the less commonly known mental health 
problems associated with smoking. In addition, the education could also incorporate 
some stress management techniques. Residents assessed as being ready to change their 
smoking behaviour, along with residents who have received intervention, could be 
offered smoking cessation, with the aid ofNRT. This may result in lower symptoms of 
stress due to the fact they would be receiving a consistent amount of nicotine throughout 
the day instead of intermittent periods ofheavy smoking. To incorporate smoking 
intervention and cessation into the TC program and assess residents' symptoms of 
anxiety, depression and stress pre and post intervention and cessation would be a useful 
direction for future research. 
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Appendix A 
Please answer all questions that apply to you and use the tick boxes where provided. 
1. What is your age? 18-25 D 25-35 D 35-45 D over 45 D 
2. What is your sex? M D F D 
3. What is your level of formal education? (Please tick box, mark all that apply) 
finished primary school D finished year 10 at secondary school D 
finished year 12 at secondary school D completed TAFE course D 
completed university degree D oth~r D 
4. How long have you been living at Cyrenian House? 0-4 weeks D 4-8 weeks D 
8-12 weeks D 12-16 weeks D 16-20 weeks D over 20 weeks D 
5. What was your main drug of concern for entering Cyrenian House? Alcohol D 
cannabis D amphetamines D heroin D other opiates D benzos D 
6. Do you currently smoke cigarettes? Y D N D 
7. Have you ever smoked cigarettes? Y D N D (only continue if answer is yes) 
8. About what age were you when you smoked your first full cigarette? Under 6 D 
6-10 D 10-14 0 14-18 D over 18 D 
9. At what age did you first start smoking on a daily basis? Under 6 D 6-10 D 
10-14 D 14-18 D 18-25 D over 25 D 
10. During the last 12 months, did you find that you couldn't stop smoking, even though 
you want to or tried to? Y D N D 
11. During the last 12 months, did you find that you couldn't cut down on your smoking, 
even though you want to or tried to? Y 0 N D 
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12. Do you want to smoke now? Y 0 N 0 
13. In the past have you .... ? (tick all that apply) 
Given up smoking (for more than a month) 0 
Tried to give up unsuccessfully 0 
Changed to a brand with lower tar or nicotine content 0 
Tried to change to a brand with lower tar or nicotine content, but unsuccessfully 0 
Reduced the amount of tobacco you smoke in a day 0 
Tried to reduce the amount of tobacco you smoke in a day, but unsuccessfully 0 
None of these 0 (skip to question 20) 
14. Which of the following motivated you to try giving up, cutting down or changing to a 
lower tar or nicotine brand? (tick all that apply) 
Health warnings on cigarette packets 0 Quit advertisements on TV 0 
Quit advertisements on radio 0 Quit advertisements in newspapers etc 0 
Advertisements for nicotine replacement products eg nicotine gum, patches, Zyban 0 
QUIT line (phone number on cigarette packet) 0 
I wanted to get fit 0 I was pregnant or wanting to start a family 0 
I thought it was affecting my health or fitness 0 My doctor advised me to give up 0 
Family and/or friends asked me to quit 0 
I was worried it was affecting the health of those around me 0 
It was costing too much money 0 
Smoking bans in public areas (e.g. restaurants, sporting venues etc.) U 
Smoking bans at work 0 Other 0 
15. Do you plan on giving up smoking .... ? 
Not in the next 6 months 0 in the next 6 months 0 in the next month 0 
I quit smoking within the last 6 months 0 I quit smoking over 6 months ago 0 
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16. Why don't you intend to quit? (Please tick all that apply) 
I enjoy smoking D smoking relaxes me D I am addicted to nicotine D 
smoking is not as bad for my health as people say D 
smoking helps manage my weight D other D 
17. Do you think that smoking decreases your stress levels? Y D N D 
18. What would motivate you to quit? (Please tick all that apply) 
Advice from my doctor D family/parents/partner D 
ill health D pregnancy D children in the home D 
affecting my fitness D 
other D 
19. During the last twelve months have you done any of the following? (tick all that 
apply) 
Rung the 'QUIT' line D Asked your doctor for help to quit D 
Used nicotine gum, nicotine patch or nicotine inhaler D 
Used a smoking cessation pill D 
Bought a product other than nicotine patch, gum or pill to help you quit D 
Read 'how to quit' literature D Used the internet to help you quit D 
Done something else to help you quit D None ofthe above D 
Don'tknow D 
20. If so, please tick any of the following that you found to be effective 
Rung the 'QUIT' line D Asked your doctor for help to quit D 
Used nicotine gum, nicotine patch or nicotine inhaler D 
Used a smoking cessation pill D 
Bought a product other than nicotine patch, gum or pill to help you quit D 
Read 'how to quit' literature D 
Don'tknow D 
Used the internet to help you quit D 
21. To what extent has entering Cyrenian House motivated you to give up smoking? 
Not at all' D not sure D very much D 
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22. What impact do you think having only one designated smoking area at Cyrenian 
House would have on your smoking? 
Reduce it slightly D Reduce it largely D No impact D 
23. Would you attempt to quit smoking during your stay at Cyrenian House if quit 
support was offered to you? Y D N D 
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AppendixB 
Fagerstrom Test for Nicotine Dependence * 
Please answer the following questions by ticking the appropriate box. 
1. How soon after you wake up do you smoke your first cigarette? 
+ After 60 minutes D 
(0) 
+ 31-60 minutes D 
(1) 
+ 6-30 minutes D 
(2) 
+ Within 5 minutes D 
(3) 
2. Do you find it difficult to refrain from smoking in places where it is forbidden? 
+NoD 
(0) 
+Yes D 
(1) 
3. Which cigarette would you hate most to give up? 
+ The first in the morning D 
(1) 
+Any other D 
(0) 
4. How many cigarettes per day do you smoke? 
+ 10 or less D 
(0) 
+11-20 D 
(1) 
+ 21-30 D 
(2) 
+ 31 or more D 
(3) 
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Please answer the following questions by ticking the appropriate box 
5. Do you smoke more frequently during the first hours after awakening than during the 
rest of the day? 
+NoD 
(0) 
+Yes D 
(1) 
6. Do you smoke even if you are so ill that you are in bed most of the day? 
+NoD 
(0) 
+Yes D 
(1) 
* Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for 
Nictoine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British 
Journal of Addictions 1991;86:1119-27 
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Appendix C 
DASS Name: Date: 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the statement 
applied to you over the past week. There are no right or wrong answers. Do not spend too much time , 
on any statement. ! 
The rating scale is as follows: 
0 Did not apply to me at all 
1 Applied to me to some degree, or some of the time 
2 Applied to me to a considerable degree, or a good part of time 
3 Applied to me very much, or most of the time 
1 I found myself getting upset by quite trivial things 
2 I was aware of dryness of my mouth 
3 I couldn't seem to experience any positive feeling at all 
4 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
5 I just couldn't seem to get going 
6 I tended to over-react to situations 
7 I had a feeling of shakiness (eg, legs going to give way) 
8 I found it difficult to relax 
9 I found myself in situations that made me so anxious I was most 
relieved when they ended 
10 I felt that I had nothing to look forward to 
11 I found myself getting upset rather easily 
12 I felt that I was using a lot of nervous energy 
13 I felt sad and depressed 
14 I found myself getting impatient when I was delayed in any way 
(eg, lifts, traffic lights, being kept waiting) 
15 I had a feeling of faintness 
16 I felt that I had lost interest in just about everything 
17 I felt I wasn't worth much as a person 
18 I felt that I was rather touchy 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
0 1 2 3 
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19 I perspired noticeably (eg, hands sweaty) in the absence of high 0 1 2 3 
temperatures or physical exertion 
20 I felt scared without any good reason 0 1 2 3 
21 I felt that life wasn't worthwhile 0 1 2 3 
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Reminder of rating scale: 
0 Did not apply to me at all 
1 Applied to me to some degree, or some of the time 
2 Applied to me to a considerable degree, or a good part of time 
3 Applied to me very much, or most of the time 
22 I found it hard to wind down 0 1 2 3 
23 I had difficulty in swallowing 0 1 2 3 
24 I couldn't seem to get any enjoyment out of the things I did 0 1 2 3 
25 I was aware of the action of my heart in the absence of physical 0 1 2 3 
exertion (eg, sense of heart rate increase, heart missing a beat) 
26 I felt down-hearted and blue 0 1 2 3 
27 I found that I was very irritable 0 1 2 3 
28 I felt I was close to panic 0 1 2 3 
29 I found it hard to calm down after something upset me 0 1 2 3 
30 I feared that I would be "thrown" by some trivial but 0 1 2 3 
unfamiliar task 
31 I was unable to become enthusiastic about anything 0 1 2 3 
32 I found it difficult to tolerate interruptions to what I was doing 0 1 2 3 
33 I was in a state of nervous tension 0 1 2 3 
34 I felt I was pretty worthless 0 1 2 3 
35 I was intolerant of anything that kept me from getting on with 0 1 2 3 
what I was doing 
36 I felt terrified 0 1 2 3 
37 I could see nothing in the future to be hopeful about 0 1 2 3 
38 I felt that life was meaningless 0 1 2 3 
39 I found myself getting agitated 0 1 2 3 
40 I was worried about situations in which I might panic and make 0 1 2 3 
a fool of myself 
41 I experienced trembling (eg, in the hands) 0 1 2 3 
42 I found it difficult to work up the initiative to do things 0 1 2 3 
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Appendix D 
Information Letter 
The Relationship between Nicotine Dependence and Symptoms of Anxiety, 
Depression and Stress in a Therapeutic Community for Alcohol and other Drug 
Rehabilitation 
(Edith Cowan University) 
Dear Participant, 
My name is Thomas Hopkins. I am conducting research on the relationship between 
nicotine dependence and symptoms of anxiety, depression and stress in a Therapeutic 
Community for alcohol and other drug rehabilitation. I would like to invite you to 
participate in my study, its findings may provide a better understanding of the 
relationship between smoking and mental health. 
You will be asked to complete three questionnaires regarding personal characteristics, 
smoking, anxiety, depression and stress which should approximately take 30 minutes. 
Participation in this study is voluntary and you will be able to withdraw at any time. The 
information gathered will remain anonymous. The service provided to you will not be 
affected in any way if you choose not to participate in the study. No persons beside my 
supervisor and I will have access to the research data. Counselling services are available 
to all participants through Edith Cowan University Psychological Services Centre on 
9301 0011, as well as a 24 hour counselling service through Lifeline on 13 1114. 
This research project is being undertaken as part of the requirements of an Honours 
program at Edith Cowan University. 
Kind regards, 
Thomas Hopkins 
Smoking, Mental Health, and AOD Treatment 76 
AppendixE 
Letter of Approval 
I have read through the proposed research and am fully aware of the nature and purpose 
ofthe research. I support the use of residents ofCyrenian House Therapeutic Community 
as participants in the proposed research. Whilst I would encourage residents to participate 
in the research, the service provided to residents will not be affected in any way if they 
choose not to participate. 
Carol Daws 
Executive Director, Cyrenian House 
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